IAM Life Sciences: Key issues for senior life sciences executives 2022
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
Stay updated with breaking news from Technology Licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
Chinese universities and public research institutes produce a large number of inventions. According to World Intellectual Property Organization data…
This month, important amendments to the Chinese Anti-Monopoly Law (AML) came into force. Implementing regulations are now being finalized which will provide further detail on each set of changes.1 The Chinese antitrust regulator, the State Administration for Market Regulation (SAMR), has concurrently proposed higher revenue thresholds for merger filings, with the final text expected by the end of…
After Serving on Delaware’s Court of Chancery, Former Vice Chancellor Slights Joins the Firm’s Corporate Governance Practice as a Partner in the Wilmington Office Contact:Wayne KesslerBaretz+Brunelle732.239.9710 Mobilewkessler@baretzbrunelle.com PALO ALTO, CA (August 8, 2022) – Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth…
Among the recently enacted changes to the Delaware General Corporation Law (DGCL) that were described in our August 1, 2022 Client Alert are some that provide more flexibility for boards of directors of Delaware corporations to delegate to management the authority to grant equity awards (for this article, this will be referred to as a management equity grant committee). These changes, which were…